Avantor, Inc. (NYSE:AVTR) Position Trimmed by Corient Private Wealth LLC

Corient Private Wealth LLC decreased its stake in Avantor, Inc. (NYSE:AVTR) by 18.5% in the fourth quarter, HoldingsChannel reports. The firm owned 26,092 shares of the company’s stock after selling 5,927 shares during the period. Corient Private Wealth LLC’s holdings in Avantor were worth $550,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. Cerity Partners LLC grew its holdings in shares of Avantor by 122.6% during the third quarter. Cerity Partners LLC now owns 30,538 shares of the company’s stock valued at $790,000 after buying an additional 16,818 shares in the last quarter. Daiwa Securities Group Inc. increased its holdings in Avantor by 11.1% in the third quarter. Daiwa Securities Group Inc. now owns 76,082 shares of the company’s stock worth $1,968,000 after buying an additional 7,592 shares during the last quarter. Bank of Montreal Can acquired a new position in shares of Avantor during the 3rd quarter worth $2,575,000. Dai ichi Life Insurance Company Ltd bought a new position in Avantor during the third quarter valued at about $497,000. Finally, FMR LLC raised its stake in shares of Avantor by 557.2% in the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company’s stock valued at $120,950,000 after acquiring an additional 3,963,912 shares in the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Avantor

In related news, CAO Steven W. Eck sold 4,907 shares of the stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares in the company, valued at approximately $711,788.12. This trade represents a 10.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares of the company’s stock, valued at $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

Avantor Trading Up 0.1 %

Shares of NYSE AVTR opened at $16.19 on Friday. Avantor, Inc. has a fifty-two week low of $15.37 and a fifty-two week high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. The firm has a market capitalization of $11.03 billion, a P/E ratio of 15.57, a P/E/G ratio of 1.55 and a beta of 1.30. The company’s 50 day simple moving average is $18.40 and its 200 day simple moving average is $21.42.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter last year, the business posted $0.22 EPS. On average, analysts predict that Avantor, Inc. will post 1.06 EPS for the current year.

Analyst Ratings Changes

AVTR has been the topic of several recent analyst reports. Stifel Nicolaus dropped their target price on shares of Avantor from $28.00 to $26.00 and set a “buy” rating on the stock in a report on Monday, February 10th. Royal Bank of Canada cut their target price on Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a research note on Monday, February 10th. Cowen reissued a “buy” rating on shares of Avantor in a research report on Tuesday, March 18th. UBS Group reissued a “neutral” rating and set a $25.00 price objective (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Finally, Barclays cut their target price on shares of Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $25.50.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.